BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10957787)

  • 1. Apical hypertrophic cardiomyopathy due to a de novo mutation Arg719Trp of the beta-myosin heavy chain gene and cardiac arrest in childhood. A case report and family study.
    Döhlemann C; Hebe J; Meitinger T; Vosberg HP
    Z Kardiol; 2000 Jul; 89(7):612-9. PubMed ID: 10957787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A high risk phenotype of hypertrophic cardiomyopathy associated with a compound genotype of two mutated beta-myosin heavy chain genes.
    Jeschke B; Uhl K; Weist B; Schröder D; Meitinger T; Döhlemann C; Vosberg HP
    Hum Genet; 1998 Mar; 102(3):299-304. PubMed ID: 9544842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of beta-myosin heavy chain mutations is reflective of their hypertrophic expressivity in patients with hypertrophic cardiomyopathy.
    Abchee A; Marian AJ
    J Investig Med; 1997 Apr; 45(4):191-6. PubMed ID: 9154300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A missense mutation in the beta myosin heavy chain gene is a predictor of premature sudden death in patients with hypertrophic cardiomyopathy.
    Marian AJ; Kelly D; Mares A; Fitzgibbons J; Caira T; Qun-Tao ; Hill R; Perryman MB; Roberts R
    J Sports Med Phys Fitness; 1994 Mar; 34(1):1-10. PubMed ID: 7934006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypertrophic obstructive cardiomyopathy due to a novel T-to-A transition at codon 624 in the beta-myosin heavy chain (beta-MHC) gene possibly related to the sudden death.
    Ohsuzu F; Katsushika S; Akanuma M; Nakamura H; Harada H; Satoh M; Hiroi S; Kimura A
    Int J Cardiol; 1997 Dec; 62(3):203-9. PubMed ID: 9476679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A malignant phenotype of hypertrophic cardiomyopathy caused by Arg719Gln cardiac beta-myosin heavy-chain mutation in a Chinese family.
    Huang X; Song L; Ma AQ; Gao J; Zheng W; Zhou X; Zhang Q; Lu H; Li Y; Liu Y; Hui R
    Clin Chim Acta; 2001 Aug; 310(2):131-9. PubMed ID: 11498078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cardiac beta-myosin heavy chain gene is not the predominant gene for hypertrophic cardiomyopathy in the Finnish population.
    Jääskeläinen P; Soranta M; Miettinen R; Saarinen L; Pihlajamäki J; Silvennoinen K; Tikanoja T; Laakso M; Kuusisto J
    J Am Coll Cardiol; 1998 Nov; 32(6):1709-16. PubMed ID: 9822100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genotype-phenotype analysis in four families with mutations in beta-myosin heavy chain gene responsible for familial hypertrophic cardiomyopathy.
    Tesson F; Richard P; Charron P; Mathieu B; Cruaud C; Carrier L; Dubourg O; Lautié N; Desnos M; Millaire A; Isnard R; Hagege AA; Bouhour JB; Bennaceur M; Hainque B; Guicheney P; Schwartz K; Komajda M
    Hum Mutat; 1998; 12(6):385-92. PubMed ID: 9829907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sudden cardiac death in hypertrophic cardiomyopathy. Variability in phenotypic expression of beta-myosin heavy chain mutations.
    Marian AJ; Mares A; Kelly DP; Yu QT; Abchee AB; Hill R; Roberts R
    Eur Heart J; 1995 Mar; 16(3):368-76. PubMed ID: 7789380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial hypertrophic cardiomyopathy and atrial fibrillation caused by Arg663His beta-cardiac myosin heavy chain mutation.
    Gruver EJ; Fatkin D; Dodds GA; Kisslo J; Maron BJ; Seidman JG; Seidman CE
    Am J Cardiol; 1999 Jun; 83(12A):13H-18H. PubMed ID: 10750581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sudden cardiac death in familial hypertrophic cardiomyopathy: are "benign" mutations really benign?
    Semsarian C; Yu B; Ryce C; Lawrence C; Washington H; Trent RJ
    Pathology; 1997 Aug; 29(3):305-8. PubMed ID: 9271024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy.
    Chida A; Inai K; Sato H; Shimada E; Nishizawa T; Shimada M; Furutani M; Furutani Y; Kawamura Y; Sugimoto M; Ishihara J; Fujiwara M; Soga T; Kawana M; Fuji S; Tateno S; Kuraishi K; Kogaki S; Nishimura M; Ayusawa M; Ichida F; Yamazawa H; Matsuoka R; Nonoyama S; Nakanishi T
    Heart Vessels; 2017 Jun; 32(6):700-707. PubMed ID: 27885498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Beta-myosin heavy-chain gene mutations in patients with hypertrophic cardiomyopathy].
    Laredo R; Monserrat L; Hermida-Prieto M; Fernández X; Rodríguez I; Cazón L; Alvariño I; Dumont C; Piñón P; Peteiro J; Bouzas B; Castro-Beiras A
    Rev Esp Cardiol; 2006 Oct; 59(10):1008-18. PubMed ID: 17125710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers.
    Michels M; Soliman OI; Phefferkorn J; Hoedemaekers YM; Kofflard MJ; Dooijes D; Majoor-Krakauer D; Ten Cate FJ
    Eur Heart J; 2009 Nov; 30(21):2593-8. PubMed ID: 19666645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in clinical expression of hypertrophic cardiomyopathy associated with two distinct mutations in the beta-myosin heavy chain gene. A 908Leu----Val mutation and a 403Arg----Gln mutation.
    Epstein ND; Cohn GM; Cyran F; Fananapazir L
    Circulation; 1992 Aug; 86(2):345-52. PubMed ID: 1638703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genotype phenotype correlations of cardiac beta-myosin heavy chain mutations in Indian patients with hypertrophic and dilated cardiomyopathy.
    Rai TS; Ahmad S; Bahl A; Ahuja M; Ahluwalia TS; Singh B; Talwar KK; Khullar M
    Mol Cell Biochem; 2009 Jan; 321(1-2):189-96. PubMed ID: 18953637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal repolarization lability in hypertrophic cardiomyopathy caused by beta-myosin heavy-chain gene mutations.
    Atiga WL; Fananapazir L; McAreavey D; Calkins H; Berger RD
    Circulation; 2000 Mar; 101(11):1237-42. PubMed ID: 10725281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coexistence of mitochondrial DNA and beta myosin heavy chain mutations in hypertrophic cardiomyopathy with late congestive heart failure.
    Arbustini E; Fasani R; Morbini P; Diegoli M; Grasso M; Dal Bello B; Marangoni E; Banfi P; Banchieri N; Bellini O; Comi G; Narula J; Campana C; Gavazzi A; Danesino C; Viganò M
    Heart; 1998 Dec; 80(6):548-58. PubMed ID: 10065021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The electrocardiogram is a more sensitive indicator than echocardiography of hypertrophic cardiomyopathy in families with a mutation in the MYH7 gene.
    al-Mahdawi S; Chamberlain S; Chojnowska L; Michalak E; Nihoyannopoulos P; Ryan M; Kusnierczyk B; French JA; Gilligan DM; Cleland J
    Br Heart J; 1994 Aug; 72(2):105-11. PubMed ID: 7848420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and prognostic evaluation of familial hypertrophic cardiomyopathy in two South African families with different cardiac beta myosin heavy chain gene mutations.
    Posen BM; Moolman JC; Corfield VA; Brink PA
    Br Heart J; 1995 Jul; 74(1):40-6. PubMed ID: 7662452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.